The Biopharma Future: A look at current trends driving volume reductions in biopharmaceutical manufacturing and keys for successful outsourcing partnerships; Contract Pharma, May 2019, Karl Pinto, CEO; Dave Cunningham, Director Corp. Dev., Goodwin Biotechnology